Posted from: Thursday, July 31, 2014 - 04:14 PM - Present

FDA Approved Rasuvo for Rheumatoid Arthritis (RA)

July 11, 2014 - The Food and Drug Administration (FDA) approved Rasuvo (methotrexate) manufactured by Medac Pharma, Inc.  Rasuvo is used to treat rheumatoid arthritis (RA), juvenile RA, and psoriasis. 

Rasuvo is administered via an auto-injector and will be available in 10 dosage strengths.  Medac Pharma is preparing to launch Rasuvo in the United States later this year.

Last Updated Wednesday, March 29, 2017 - 07:10 AM.